Jeremy L. Stigall - 10 Jun 2022 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role: GM, Biologics & Drug Delivery
Signature: /s/ Richard F. Mattern by Power of Attorney for Jeremy L. Stigall
Issuer symbol: CLPT
Transactions as of: 10 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 14 Jun 2022, 16:15:55 UTC
Previous filing: 19 May 2022
Next filing: 08 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLPT	Common Stock	Award	$0	+17,528	+68%	$0.000000	43,211	10 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLPT	Stock Option (Right to Buy)	Award	$0	+11,685		$0.000000	11,685	10 Jun 2022	Common Stock	11,685	$11.41	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.
F2	The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.